IntelGenx Corp.

IntelGenx to Present at the Singular Research 10th Annual ‘Best Of The Uncovereds’ Global Investment Conference

IntelGenx Corp. and RedHill Biopharma Ltd Announce Positive Outcome of the Decentralized Procedure for Approval of RIZAPORT(TM) in Europe

IntelGenx to Present at the 17th Annual Rodman & Renshaw Global Investment Conference

IntelGenx Reports Q2 and First Six Months 2015 Results and Provides Corporate Development Update

IntelGenx to Provide Second Quarter 2015 Update on August 10, 2015

IntelGenx Announces Appointment of New Director

IntelGenx Appoints Andre Godin as New Executive Vice-President and Chief Financial Officer

IntelGenx Reports Q1, 2015 Results and Provides Corporate Development Update

IntelGenx Confirms Execution of Lease and Construction Agreements

IntelGenx Reports 2014 Annual Results and Provides Corporate Development Update